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Hypomorphic mutations in these genes impair postsynaptic differentiation. The number of AChRs at synapses is reduced, which compromises the reliability of synaptic transmission and leads to muscle weakness and fatigue.
Mutations in these genes impair synaptic transmission, leading to muscle weakness and fatigue. ChAT encodes the enzyme for synthesizing ACh, and Nav1.4 encodes a voltage-activated sodium channel expressed in skeletal muscle.
Cause accelerated degradation of AChRs and structural disorganization of the synapse, leading to Myasthenia Gravis Cause structural disorganization of the synapse, leading to Myasthenia Gravis.
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See online version for legend and references. The neuromuscular synapse-the connection between motor neurons and skeletal muscle-controls our ability to move and breath, and thus, it is essential for survival. Motor nerve terminals release the neurotransmitter acetylcholine (ACh), which diffuses across the synaptic cleft and binds to acetylcholine receptors (AChRs) in the muscle membrane. Binding of ACh opens the ligand-gated channel and depolarizes the muscle membrane, which initiates an action potential that stimulates muscle contraction. AChRs must be concentrated in the postsynaptic membrane at extremely high density, greater than 10,000 AChRs/um2, to ensure that ACh elicits a sufficient depolarization of the muscle membrane potential to trigger the action potential mechanism. This reliability is achieved by two general mechanisms: (1) anchoring AChRs (through rapsyn) and other critical muscle-derived proteins in the postsynaptic membrane, and (2) selectively increasing expression of these genes in myofiber nuclei positioned near the synaptic site, a process called "synapse-specific transcription." In addition, robust synaptic transmission relies upon the organization and alignment of active zones, or neurotransmitter release sites, in the nerve terminal directly opposed to AChRs in the muscle.
This SnapShot illustrates the molecules and mechanisms that are currently known to lead to this specialized organization of the muscle plasma membrane at the neuromuscular synapse, a process called "synaptic differentiation." Defects in these pathways lead to neuromuscular diseases called congenital myasthenia, typified by muscle weakness and fatigue. The molecules and mechanisms that direct the formation and maintenance of neuromuscular synapses are likely similar to those in synapses of the central nervous system, where these signaling mechanisms are less well understood. Therefore, understanding how neuromuscular synapses form and work remains a paradigm for elucidating principles that can then be applied to less accessible synapses in the central nervous system.
Synapse Formation
Muscles are prepatterned with regions of increased AChR transcription (blue) and AChR clustering (red) in the central, prospective synaptic region of muscle prior to and independent of innervation. Muscle prepatterning requires low-density lipoprotein receptor-related protein 4 (Lrp4) and (muscle-specific kinase) MuSK and specifies the region where motor axons form synapses, marked by nerve terminals juxtaposed to AChRs.
Motor nerve terminals focally release agrin. Agrin is a large glycoprotein that stabilizes postsynaptic differentiation at preexisting sites by binding Lrp4 and activating MuSK. Agrin can also induce new postsynaptic specializations. Therefore, the final cohort of synapses on the muscle fiber includes those recognized by motor axons and those induced by motor axons.
ACh depolarizes muscle, disperses AChRs that are not juxtaposed to nerve terminals, and antagonizes postsynaptic differentiation by mechanisms that are poorly understood. In contrast, Agrin overcomes the extinguishing activity of ACh and selectively stabilizes postsynaptic differentiation at synapses. Binding of Agrin to Lrp4 stimulates association between Lrp4 and MuSK and increases MuSK kinase activity. Phosphorylation of Y553 in the juxtamembrane region of MuSK stimulates recruitment and tyrosine phosphorylation of Dok-7. This causes Dok-7 to dimerize, stimulate MuSK kinase activity, and then recruit CT10 regulator of kinase (Crk) and Crk-L. Formation of a MuSK/Dok-7-signaling complex is essential to activate both a Rac/Rho-dependent and a Rapsyn-dependent pathway, which leads to the anchoring and clustering of AChRs. Crk/Crk-L directly activates Rho GTPases, dishevelled (Dvl), kinases (e.g., Pak, Abl1/2), and a cochaperone of the heat shock protein (i.e., Tid1).
The pathway that activates transcription specifically at the synapse is not as well understood. However it likely involves activation of the E-twenty six (Ets) family of transcription factors in a JNK-dependent manner. ETS transcription factors stimulate expression of multiple genes encoding synaptic proteins, including AChR, MuSK, Lrp4, acetylcholinesterase (AchE), and utrophin. In the SnapShot, fundamental components of neuromuscular synapse formation are large and in bold, whereas if genetic evidence for their suggested role in synapse formation is lacking, the protein name is smaller.
Synapse Maintenance
Maintaining neuromuscular synapses requires the continual action of genes that are necessary for synapse formation as well as additional genes essential to stabilize neuromuscular synapses. These include proteins that regulate postsynaptic maturation, such as Src-family kinases, a-dystrobrevin, LL5b, Syne-1, and collagen XIII, as well as proteins that regulate presynaptic differentiation, including fibroblast growth factors (FGFs), collagen IV, beta2-laminins, and CD24.
